Skin electroporation for transdermal and topical drug delivery

Transdermal Drug Delivery, Second Edition: Revised and Expanded

Volumn , Issue , 2002, Pages 227-254

  Préat, Véronique ^a   Vanbever, Rita ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 10644232080     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (94)

1. A Badkar, G Betageri, G Hofmann, A Banga. Enhancement of transdermal ionto-phoretic delivery of a liposomal formulation of colchicine by electroporation. Drug Del 6:111-115, 1999.
2. A Banga, ed. Electrically-assisted transdermal and topical drug delivery. Bristol, PA: Taylor and Francis, 1998.
3. A Banga, M Prausnitz. Delivery of protein and gene-based drugs by skin electroporation. Trends Biotech 16:408-412, 1998.
4. A Banga, S Bose, T Ghosh. Iontophoresis and electroporation: comparisons and contrasts. Int J Pharm 179:1-19, 1999.
5. D Bommannan, J Tamada, L Leung, RO Potts. Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro. Pharm Res 11:1809-1814, 1994.
6. RM Brand and PL Iversen. Iontophoretic delivery of telomeric oligonucleotides. Pharm Res 13:851-854, 1996.
7. DC Chang, BR Chassy, JA Saunders, A Sowers, eds. Guide to Electroporation and Electrofusion. New York: Academic Press, 1992.
8. T Chen, EM Segall, R Langer, JC Weaver. Skin electroporation: rapid measurements of the transdermal voltage and flux of four fluorescent molecules show a transition to large fluxes near 50 V. J Pharm Sci 37:1368-1374, 1998a.
9. T Chen, R Langer, JC Weaver. Skin electroporation causes molecular transport across the stratum corneum through localized transport regions. J Inv Dermatol Symp Pro 3:159-165, 1998b.
10. T Chen, R Langer, JC Weaver. Charged microbeads are not transported across the human stratum corneum in vitro by short high-voltage pulses. Bioelec-trochem Bioenerg 48:181-192, 1999.
11. YA Chizmadzhev, VG Zarnytsin, JC Weaver, RO Potts. Mechanism of electroinduced ionic species transport through a multilamellar lipid bilayer system. Biophys J 68:749-765, 1995.
12. YA Chizmadzhev, AV Indenbom, PI Kuzmin, SV Galichenko, JC Weaver, RO Potts. Electrical properties of skin at moderate voltages: contribution of appendageal macropores. Biophys J 74:843-856, 1998a.
13. Y Chizmadzhev, P Kuzmin, J Weaver, R Potts. Skin appendageal macropores as a possible pathway for electrical current. J Invest Dermatol Symp 3: 148-152, 1998b.
14. N Dujardin, P Van der Smissen, V Préat. Topical gene transfer into rat skin using electroporation. Pharm Res 18:61-66, 2001.
15. N Dujardin, E Staes, V Préat. Needle free immunization using skin electroporation. Proc Controlled Release of Bioactive Material 27, 2000.
16. N Dujardin, E Staes, Y Kalia, P Clarys, RH Guy, U Préat. In vivo assessment of skin electroporation using square wave pulses. J Control Release 79: 219-227, 2002.
17. DA Edwards, MR Prausnitz, R Langer, JC Weaver. Analysis of enhanced transdermal transport by skin electroporation. J Control Rel 34:211-221, 1995.
18. S Gallo, AR Oseroff, PG Johnson, SW Hui. Characterization of electric-pulse-induced permeabilization of porcine skin using surface electrodes. Biophys J 72:2805-2811, 1997.
19. S Gallo, A Sen, M Hensen, S Hui. Time-dependent ultrastructural changes to porcine stratum corneum following an electric pulse. Biophys J 76:2824-2832, 1999.
20. EA Gift, JC Weaver. Observation of extremely heterogenous electroporative molecular uptake by Saccharomyces cerivisiae which changes with electric field pulse amplitude. Biochim Biophys Acta 1234:52-62, 1995.
21. GM Glenn, GR Matyas, CR Alving. Skin immunization made possible by cholera toxin. Nature 391:351, 1998.
22. P Green. Iontophoretic delivery of peptides drugs. J Control Release 41:33-48,1996.
23. T Gowrishankar, T Herndon, T Vaughan, J Weaver. Spatially constrained localized transport regions due to skin electroporation. J Control Rel 60:101-110, 1999.
24. RH Guy Current status and future prospects of transdermal drug delivery. Pharm Res 13:1765-1768, 1996.
25. J Hadgraft, RH Guy, eds. Transdermal Drug Delivery: Development Issues and Research Initiatives. New York, Marcel Dekker, 1989.
26. R Heller, R Gilbert, MJ Jaroszeski. Clinical applications of electrochemotherapy. Adv Drug Del Rev 35:119-129, 1999.
27. GA Hofmann, WV Rustrum, KS Suder. Electro-incorporation of microcarriers as a method for the transdermal delivery of large molecules. Bioelectrochem Bioenerg 38:209-222, 1995.
28. L Illic, T Gowrishankar, T Vaughan, T Herndon, J Weaver. Spatially constrained skin electroporation with sodium thiosulfate and urea creates transdermal microconduits. J Control Rel 61:185-202, 1999.
29. A Jadoul, V Preat. Electrically-enhanced transdermal delivery of domperidone. Int Pharm 154:229-234, 1997.
30. A Jadoul, V Regnier, J Doucet, D Durand, V Preat. X-ray scattering analysis of the stratum corneum treated by high voltage pulses. Phar Res 14:1275-1277, 1997.
31. A Jadoul, H Tanajo, V Preat, F Spies, H Bodde. Electroperturbation of human stratum corneum fine structure by high voltage pulses: a freeze fracture electron microscopy and differential thermal analysis study. J Invest Dermatol Symp Proc 3:153-158, 1998a.
32. A Jadoul, N Lecouturier, J Mesens, W Caers, V Preat. Electrically enhanced transdermal delivery of alnitidan. J Control Rel 54:265-272, 1998b.
33. A Jadoul, J Bouwstra, V Preat. Effects of iontophoresis and electroporation on the stratum corneum. Review of the biophysical studies. Adv Drug Del Rev 35:89-105, 1999.
34. PG Johnson, SA Gallo, SW Hui, A Oseroff. A pulsed electric field enhances cutaneous delivery of methylene blue in excised full-thickness porcine skin. J Invest Dermatol 111:457-463, 1998.
35. J Kost, U Pliquett, S Mitragotri, A Yamamoto, R Langer, J Weaver. Synergistic effect of electric field and ultrasound on transdermal transport. Pharm Res13:633-638, 1996.
36. S Mitragotri, D Blankschtein, R Langer. Ultrasound—mediated transdermal protein delivery. Science 269:850-853, 1995.
37. C Lombry, N Dujardin, V Preat. Transdermal delivery of macromolecules using skin electroporation. Pharm Res 17(1), 2000.
38. L Mir, S Orlowski. Mechanisms of electrochemotherapy. Adv Drug Del Rev 35: 107-118, 1999.
39. A Misra, S Ganga, P Upadhay. Needle-free non-adjuvanted skin immunization by electroporation-enhanced transdermal delivery of diphtheria toxoid and a candidate peptide vaccine against hepatitis B virus. Vaccine 18:517-523, 1999.
40. S Mitragotri, D Blankschtein, R Langer. Ultrasound-mediated transdermal protein delivery. Science 269:850-853, 1995.
41. M Okino, H Tomie, H Kanesada, M Marumoto, K Esato, H Suzukiu. Optimal electric conditions in electrical impulse chemotherapy. Jpn J Cancer Res83:1095-1101, 1992.
42. U Pliquett. Mechanistic studies of molecular transdermal transport due to skin electroporation. Adv Drug Deliv Rev 35:41-60, 1999.
43. U Pliquett, JC Weaver. Electroporation of human skin: simultaneous measurement of changes in the transport of two fluorescent molecules and in the passive electrical properties. Bioelectrochem Bioenerg 39:1-12, 1996a.
44. U Pliquett, JC Weaver. Transport of a charged molecule across the human epidermis due to electroporation. J Control Rel 38:1-10, 1996b.
45. U Pliquett, MR Prausnitz, YA Chizmadzhev, J Weaver. Measurement of rapid release kinetics for drug delivery. Pharm Res 12:549-555, 1995 (errata in PharmRes 12:1244, 1995a).
46. U Pliquett, R Langer, JC Weaver. Changes in the passive electrical properties of human stratum corneum due to electroporation. Biochim Biophys Acta1239:111-121, 1995b.
47. U Pliquett, EA Gift, JC Weaver. Determination of the electric field and anomalous heating caused by exponential pulses in electroporation experiments. Bioelectrochem Bioenerg 39:39-53, 1996a.
48. U Pliquett, TE Zewert, T Chen, R Langer, JC Weaver. Imaging of fluorescent molecule and small ion transport through human stratum corneum during high voltage pulsing: localized transport regions are involved. Biophys Chem 58:185-204, 1996b.
49. U Pliquett, R Vanbever, V Préat, JC Weaver. Local transport regions in human stratum corneum due to short and long high-voltage pulses. Bioelectro Bioener 47:151-161, 1998.
50. RO Potts, D Bommannan, O Wang, JA Tamada, JE Riviere, NA Monteiro-Riviere. Transdermal peptide delivery using electroporation. Pharm Bio-technol 10:213-238, 1997.
51. MR Prausnitz. The Effects of electric current applied to the skin: a review for transdermal drug delivery. Adv Drug Deliv Rev 18:395-425, 1996a.
52. MR Prausnitz. Do high-voltage pulses cause changes in skin structure? J Control Rel 40:321-326, 1996b.
53. MR Prausnitz. Reversible skin permeabilization for transdermal delivery of macromolecules. Crit Rev Ther Drug Carrier Syst 14:455-483, 1997.
54. M Prausnitz. A practical assessment of transdermal drug delivery by skin electroporation. Adv Drug Del Rev 35:61-76, 1999.
55. MR Prausnitz, VG Bose, R Langer, JC Weaver. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA 90:10504-10508, 1993a.
56. MR Prausnitz, DS Seddick, AA Kon, VG Bose, S Frankenburg, SN Klaus, R Langer, JC Weaver. Methods for in vivo tissue electroporation using surface electrodes. Drug Deliv 1:125-131, 1993b.
57. MR Prausnitz, U Pliquett, R Langer, JC Weaver. Rapid temporal control of transdermal drug delivery by electroporation. Pharm Res 11:1834-1837, 1994.
58. MR Prausnitz, ER Edelman, JA Gimm, R Langer, JC Weaver. Transdermal delivery of heparin by skin electroporation. Bio/Technology 13:1205-1209, 1995.
59. MR Prausnitz, JA Gimm, RH Guy, R Langer, JC Weaver, C Cullander. Imaging of transport pathways across human stratum corneum during high-voltage and low-voltage electrical exposures. J Pharm Sci 85:1363-1370, 1996a.
60. MR Prausnitz, CS Lee, CH Liu, JC Pang, T-P Singh, R Langer, JC Weaver. Transdermal transport efficiency during skin electroporation and iontophoresis. J Control Rel 38:205-217, 1996b.
61. V Preat, R Vanbever, A Jadoul, V Regnier. Electrically enhanced transdermal drug delivery: iontophoresis vs. electroporation. In: Transdermal Drug Delivery. A Case Study, Iontophoresis. P Couvreur, D Duchene, P Green and H Junginger, eds. Paris: Editions de la Sante, 1997, pp 58-67.
62. V Regnier, V Preat. Localisation of an FITC-labeled phosphorothioate oligo-deoxynucleotide in the skin after topical delivery by iontophoresis and electroporation. Pharm Res 15:1596-1602, 1998a.
63. V Regnier, V Preat. Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation. Int J Pharm 184:147-156, 1999.
64. V Regnier, T Le Doan, V Preat. Parameters controlling topical delivery of oligo nucleotides by electroporation. J Drug Target 5:275-289, 1998.
65. V Regnier, A Tahiri, Andre M Lemaître, T Le Doan, V Preat. Electroporation mediated delivery of 3'-protected phosphodiester oligodeoxynucleotides to the skin. J Control Release, in press.
66. JE Riviere, NA Monteiro-Riviere, RA Rogers, D Bommannan, JA Tamada, RO Potts. Pulsatile transdermal delivery of LHRH using electroporation: drug delivery and skin toxicology. J Control Rel 36:229-233, 1995.
67. EW Smith, H Maibach, eds. Percutaneous Penetration Enhancers. Boca Raton, FL: CRC Press, 1995.
68. SI Sukharev, VA Klenchin, SM Serov, LV Chernomordik, YA Chizmadzhev. Electroporation and electrophoretic DNA transfer into cells. The effect of DNA interaction with electropores. Biophys J 63:1320-1327, 1992.
69. AV Titomirov, S Sukharev, E Kistanova. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim Biophys Acta 1088:131-134, 1991.
70. N Turner, L Ferry, M Price, C Cullander, RH Guy. Iontophoresis of poly-lysines: the role of molecular weight. Pharm Res 14:1322-1331, 1997.
71. R Vanbever, N Lecouturier, V Preat. Transdermal delivery of metoprolol by electroporation. Pharm Res 11:1657-1662, 1994.
72. R Vanbever, V Preat. Factors affecting transdermal delivery of metoprolol by electroporation. Bioelectrochem Bioenerg 38:223-228, 1995.
73. R Vanbever, V Preat. In vivo efficacy and safety of skin electroporation. Adv Drug Del Rev 35, 77-88, 1999.
74. R Vanbever, E Le Boulange, V Préat. Transdermal delivery of fentanyl by electroporation. I. Influence of electrical factors. Pharm Res 13:559-565, 1996a.
75. R Vanbever, N De Morre, V Preat. Transdermal delivery of fentanyl by electroporation. II. Mechanisms involved in drug transport. Pharm Res 13:1359-1365, 1996b.
76. R Vanbever, MR Prausnitz, V Preat. Macromolecules as novel transdermal transport enhancers for skin electroporation. Pharm Res 14:638-644, 1997.
77. R Vanbever, G Langers, S Montmayeur, V Préat. Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation. J Control Rel 50: 225-235, 1998a.
78. R Vanbever, D Fouchard, A Jadoul, N De Morre, V Préat, J-P Marty. In vivo noninvasive evaluation of hairless rat skin after high-voltage pulse exposure. Skin Pharmacol Appl Skin Physiol 11:23-34, 1998b.
79. R Vanbever, M-A Leroy, V Préat. Transdermal permeation of neutral molecules by electroporation. J Control Rel 54:243-250, 1998c.
80. R Vanbever, UF Pliquett, V Préat, JC Weaver. Comparaison of the effects of short, high-voltage and long, medium voltage pulses on skin electrical and transport properties. J Control Rel 69:35-47, 1999.
81. KA Walters, J Hadgraft, eds. Pharmaceutical Skin Penetration Enhancement. New York: Marcel Dekker, 1993.
82. S Wang, M Kara, RR Krishnan. Transdermal delivery of cyclosporin-A using electroporation. J Control Rel 50:61-70, 1998a.
83. S Wang, M Kara, RR Krishnan. Topical delivery of cyclosporin-A coevaporate using electroporation. Technique Drug Dev. Ind. Pharm 23:657-998, 1998b.
84. JC Weaver. Electroporation: a general phenomenon for manipulating cells and tissues. J Cell Biochem 51:426-435, 1993.
85. JC Weaver. Electroporation theory: concepts and mechanisms. In: JA Nickoloff, ed. Molecular Biology: Methods, 1995.
86. JC Weaver, YA Chizmadzhev. Theory of electroporation: a review. Bioelectro-chem Bioenerg 41:135-160, 1996.
87. JC Weaver, R Vanbever, TE Vaughan, MR Prausnitz. Heparin alters transdermal transport associated with electroporation. Biochem Biophys Res Com 234: 637-640, 1997.
88. JC Weaver, TE Vaughan, Y Chizmadzhev. Theory of skin electroporation: implications of straight-through aqueous pathway segments that connect adjacent corneocytes. J Invest Dermatol Symp Proc 3:143-147, 1998.
89. J Weaver, T Vaughan, Y Chizmadzhev. Theory of electrical creation of aqueous pathways across skin transport barriers. Adv. Drug Del Rev 35:21-39, 1999.
90. TE Zewert, UF Pliquett, R Langer, JC Weaver. Transdermal transport of DNA antisense oligonucleotides by electroporation. Biochem Biophys Res Com212:286-292, 1995.
91. TE Zewert, U Pliquett, R Vanbever, T Chen, R Langer, JC Weaver. Creation of transdermal pathways for macromolecule transport by skin electroporation and a low toxicity pathway-enlarging molecule. Bioelectrochem Bioenerg. 49:11-20, 1999.
92. L Zhang, L Li, GA Hofmann, RM Hoffman. Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin aging and other diseases. Biochem Biophys Res Comm 220:633-636, 1996.
93. L Zhang, L Li, ZL An, RM Hoffman, GA Hofmann. In vivo transdermal delivery of large molecules by pressure-mediated electroincorporation and electroporation: a novel method for drug and gene therapy. Bioelectrochem Bioen-erg 42:283-292, 1997.
94. L Zhang, S Lerner, WV Rustrum, GA Hofmann. Electroporation mediated topical delivery of vitamin C for cosmetic applications. Bioelectrochem Bioenerg, 48:453-461, 1999.